t: +44 (0) 1727 809917

e: info@healthcare-ed.com

web stats

Hematologic Cancers: An Introduction

24-25 Oct 2017 Newark, NJ, USA Price: USD 4,995

Registration for this hematologic cancers course is advised by: Monday 18th September 2017

What is Hematologic Cancers – An Introduction ?

Hematologic Cancers – An Introduction is a two-day, rapid and progressive face-to-face training program.  Led by specialist physicians delegates are provided with a comprehensive review of the hematological system and provides an overview on the spectrum of hematologic cancers. This course equips attendees with the knowledge to discuss Hematologic Cancers confidently and credibly.

Hematologic Cancers – An Introduction is a high calibre training program led by teams of specialist physicians, it is ideal for the pharmaceutical, medical technology and biotechnology industries. Case studies and open discussion form an integral part of the program.

What will I learn from this hematologic cancers training course?

This hematologic cancers learning program includes:

  • Discussion on the pathophysiology of hematological malignancies such as leukemias, lymphomas and myeloma
  • Common treatments & management of these hematological malignancies
  • The challenges these treatments present to patients
  • Review of the issues and complications of bone marrow and stem cell transplant

Topics included in this hematologic cancers course:

  • The formation and maturation of blood cells
  • Classification and epidemiology of hematological malignancies
  • Presentations, diagnosis and staging
  • Chemotherapy and irradiation
  • Clinical trial issues

Faculty includes:

Dennis Cooper MD, Professor of Medicine (Hematology), Yale School of Medicine, New Haven, USA
Louis F Diehl MD, Associate Professor of Medicine & Oncology, Director, Myeloma Program, Division of Hematological Malignancies, John Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, USA
Carol Ann Huff MD, Associate Professor of Medicine and Oncology, Director, Myeloma Program, Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Mark Levis MD, Associate Professor of Oncology, Pharmacology, and Medicine at Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Douglas Smith MD, Associate Professor, Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA

Hematologic Cancers Course

Is this hematologic cancers course for me?

This hematological cancers training is designed to meet the broad information and education requirements of a range of pharmaceutical and biotech personnel from R&D, medical affairs, regulatory, strategic marketing and and many others from both science and business functions.

4995